Peer-reviewed veterinary case report
Palliative treatment options for oral melanoma in dogs
By C.M. Gonzalez-Zambrano et al.·Published in Arquivo Brasileiro de Medicina Veterinária e Zootecnia·2025·View original on DOAJ →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Palliative therapeutic intervention in canine oral melanoma: adjuvant treatment approach
- Species:
- dog
Plain-English summary
A 13-year-old female dog was diagnosed with advanced oral melanoma, a type of cancer that affects the mouth. To manage her condition, the veterinarian used a combination of medications, including cyclophosphamide and piroxicam, along with a special low-carbohydrate diet and cannabis extracts. This treatment helped keep the cancer stable for about 194 days, allowing her to maintain a good quality of life. Unfortunately, after about 218 days, the tumor began to grow again, leading to the difficult decision of euthanasia. This case highlights the potential benefits of combining different therapies for managing oral tumors in dogs.
People also search for: dog oral melanoma treatment · canine cancer diet · palliative care for dogs with cancer
Abstract
ABSTRACT Oral neoplasms are classified as non-odontogenic, predominantly malignant, and odontogenic, typically benign. Melanoma is a malignant tumor arising from melanocytes and nevus cells, found in the skin and mucous membranes, with increasing incidence and high mortality. In the oral cavity, although rare, it primarily affects the palate-alveolar mucosa. Diagnosis is made through histopathology and immunohistochemistry, with surgical intervention being the primary treatment. However, metronomic therapies combined with immunotherapy and nutritional management show promise in inoperable cases. This case report discusses a 13-year-old female canine with advanced oral melanoma. The treatment regimen included cyclophosphamide, piroxicam, a non-specific immunostimulant, a low-carbohydrate diet, and CBD and THC extracts. The disease remained stable for 194 days, maintaining quality of life. However, at 218 days, tumor progression resumed, leading to euthanasia. This case suggests that metronomic therapy combined with immunotherapy and nutritional management may slow disease progression, although further research is needed to validate these findings in a larger cohort. Additionally, non-specific immunotherapy and the use of cannabis extracts could be valuable additions to the treatment of oral neoplasms in veterinary medicine.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on DOAJ: https://doi.org/10.1590/1678-4162-13438